UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities and Exchange Act of 1934
Date of Report (Date of earliest reported): March 28, 2008
(Exact name of registrant as specified in charter)
| Utah | 000-26753 | 87-0416131 |
| (State or Other Jurisdiction of Incorporation or Organization) | (Commission File Number) | (IRS Employer Identification No.) |
43 West 33rd Street
New York, New York 10001
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (212) 695-3334
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02 | Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers. |
On March 28, 2008, Simcha Edell and Mechael Kanovsky resigned as executive officers of the Amazon Biotech, Inc. (the “Company”) and Eliyahu Bental Tolchinsky was appointed as the Chief Executive Officer and President of the Company. Further, Mr. Tolchinsky was appointed as a director of the Company.
Mr. Tolchinsky, since 2007, has been employed by Webb & Associates in Rechovot, Israel, with their patent department and with Mazal Pharmaceuticals, Inc. since May 2008. From 2006 through 2007, Mr. Tolchinsky served as an editor for Hadassah Ein Kerem Hospital, Jerusalem, Israel, as an attorney for R.A.M. Technologies, Jerusalem, Israel in their patent department. During 2005, Mr. Tolchinsky served in the grants department for Halsey Group and from 2004 through 2005, Mr. Tolchinsky served in the grants department of Freemind Consultants in Jerusalem, Israel. Mr. Tolchinsky received his BA from Cornell University in 1989 and his JD from Tulane University in 1992. Mr. Tolchinsky’s email is eb@amazonbiotech.org.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | |
| | AMAZON BIOTECH, INC. |
|
|
|
| Date: May 6, 2008 | By: | /s/ Eliyahu BenTal Tolchinsky |
| | Name: | Eliyahu Bental Tolchinsky |
| | Title: | CEO |
